Welcome to Part 2 of the 2025 ASCO ASM Special of The Oncology Journal Club! Our Host Craig Underhill is joined by Dr Kate Clarke and Professor Christopher Jackson to unpack practice changing presentations from Chicago.
Results from VERITAC-2, the first global phase 3 clinical trial of a PROTAC, a targeted…
Results from an international phase 3 clinical trial show that treatment with sacituzumab govitecan and…
Results from an international clinical trial show that a 14-gene molecular assay can help identify…
Late-breaking data from the Phase III NAPOLI 3 study were presented today at the 2025…
An immunotherapy helps patients live years longer without their cancer getting worse or coming back,…
Results from the international phase 3 NIVOPOSTOP clinical trial found that adding nivolumab to chemoradiotherapy…
Results from a large, prospective cohort study show that eating a less inflammatory diet may…
In patients with an advanced type of skin cancer called cutaneous squamous cell carcinoma (cSCC),…
Patients with advanced gastric or gastro-oesophageal junction (GEJ) cancer treated with CAR T-cell therapy lived…